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Abstract
Two alpha1-globulin bands of fetal serum with relative mobilities against bromophenol blue
of 0.55 and 0.58 on 7% polyacrylamide gel electrophoresis reacted with a monospecific rabbit
antiserum to alpha-fetoprotein (AFP). The former globulin band was clearly detected in the fe-
tal liver supernatant. AFP was immunochemically purified from both the fetal serum and liver,
and their electrophoretic and immunochemical properties were compared. Liver AFP purified
by immunoadsorbent column yielded electrophoretic mobilities and relative amounts of the two
electrophoretically distinct components identical with the purified serum AFP. The immunolog-
ical reactivity of the two components of the purified preparations from serum and liver against
the monospecific anti-AFP serum was also indistinguishable. After the removal of the sialic
acid residues from purified serum and liver AFP by treatment with neuraminidase for 6 to 12
hr, disc electrophoretic patterns on 5% polyacrylamide gel and immunoelectrophoretic patterns
of the treated AFP were found to be closely similar in both preparations. It may be possible to
conclude that serum and liver AFP are structurally indistinguishable and probably identical.
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Ahstract: Two alphal-globulin bands of fetal serum with relative
mobilities against bromophenol blue of 055 and 0.58 on 7% polyacry-
lamide gel electrophoresis reacted with a monospecific rabbit anti.
serum to alpha-fetoprotein (AFP). The former globulin band was
clearly detected in the fetal liver supernatant. AFP was immuno-
chemically purified from both the fetal serum and liver, and their elec.
trophoretic and immunochemical properties were compared. Liver
AFP purified by immunoadsorbent column yielded electrophoretic
mobilities and relative amounts of the two electrophoretically distinct
components identical with the purified serum AFP. The immunologi.
cal reactivity of the two components of the purified preparations from
serum and liver against the monospecific anti.AFP serum was also
indistinguishable. After the removal of the sialic acid residues from
purified serum and liver AFP by treatment with neuraminidase for 6
to 12 hr, disc electrophoretic patterns on 5% polyacrylamide gel and
immunoelectrophoretic patterns of the treated AFP were found to be
closely similar in both preparations. It may be possible to conclude
t;at serum and liver AFP are structurally indistinguishable and prob-
ably identical.
Rat alpha-fetoprotein (AFP) purified from fetal serum (1) or adult serum
with hepatom::t (2) was separated into two immunologically identical com-
ponents with different charges by conventional polyacrylamide gel electro-
phoresis. Our previous studies of their physicochemical and immunological
propertie~ (3) have revealed that AFPa and AFPb, the two AFP components
of rat, contain at least 2.5 and 4.5 molecules of sialic acid per mole of feto-
protein, respectively, and that negative charges other than the carboxyl
groups of sialic acid are required for AFPa to move faster than AFPb at an
alkaline pH by disc electrophoresis.
It has been established that AFP is synthesized mainly in the fetal liver
with a trace production in the yolk sac of rats (4). However, whether the
two components of rat AFP are synthesized de no~o in the fetal liver under
a genetically controlled mechanism or modified in charge after synthesis is
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unknown at present. The binding of sialic acid, hexoseamine and other
hexoses to serum glycoproteins occurs after the synthesis of proteins and may
affect their metabolic function and degradation (5, 6). These considerations
led us to investigate the electrophoretic and immunological properties of AFP
circulating in the blood and the newly synthesized AFP in the liver. In this
report, the results of comparative studies on the immunochemical properties
of serum and liver AFP prepared by an immunoadsorbent column are de-
scribed.
MATERIALS AND METHODS
Animals: Sprague-Dawley rats were used in the present experiment unless
otherwise stated. Rat fetuses were obtained by cesarean section of female rats
of the same strain at 15 20th days of pregnancy. The serum and liver samples
were collected after decapitation. The preparation of liver supernatant was
carried out as described in our previous paper (7).
Preparation of antiserum: Male rabbits were immunized by subcutaneous
injections of pooled fetal serum, and a monospecific anti-AFP serum was ob-
tained by absorbing 30 ml of whole antifetal-serum-immune serum with 10 ml
of pooled adult serum and further with 13 ml of cadmium chloride-poisoned rat
serum, as described previously in detail (8). Immunological properties of anti-
AFP serum thus obtained have already been reported (8).
Analytical techniques: The following techniques were employed as reported
originally-vertical disc electrophoresis on 5 or 7% polyacrylamide gels at 4D C
for 60 70 min with a constant current of 4 rnA per tube (5x90 mm) (9), relative
mobilities against bromophenol blue (R"PB) as a marker being determined for
identification of AFP components; immunoelectrophoresis (10) ; agar double-
diffusion test (11); and determination of AFP concentration by a double-anti-
body technique with 1311 or 1251_labeled AFP (12). The protein was stained
with Amido Schwarz. Densitometric profiles were recorded by a Fujiox den-
sitometer.
Neuraminidase treatment of AFP: In incubation of AFP with neuraminidase
(type VI, chromatographically purified from Clostridium perfringens) at 37 D C for
6 hr, 0.64 unit of the enzyme per mg AFP at a final concentration of 0 5 mg per
ml was used. However, for 12 hr-treatment, 20 milliunits of fresh enzyme
were further added after 6 hr of incubation to achieve complete hydro1ysis.
Materials: Freund's complete adjuvant and Noble agar were purchased
from Difco Laboratories Inc. and neuraminidase from Sigma Chemical Co.
Cyanogen bromide-activated Sepharose 4B and Sephadex G-200 were purchased
from Pharmacia Fine Chemicals AB. Other reagents used were purchased from
sources reported previously (1, 3, 7,8).
RESULTS
Electrophoretic and imm:mochemical properties of fetal senm and lil:er
supernatant proteins: Disc electrophoretic patterns of fetal serum and liver
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supernatant proteins were compared to those of the respective adult proteins.
The presence of two bands with R BP13 of 0.55 and 0.58, which were located
between albumin and alphal-globulin, was the most outstanding feature in
fetal serum (Fig. 1). The fetal liver proteins yielded only the former protein
+
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Fig. 1. Disc electrophoretic patterns of serum and liver supernatant proteins
from adult and fetal rats. Three pI of serum and 10 pI of liver supernatant were
put on 70/0 polyacrylamide gel columns and electrophoresed for 60 min at 4°C and
4 rnA/tube. Samples applied on columns were as follows: 1, adult serum; 2, fetal
serum; 3, liver supernatant of adult rat; and 4, liver supernatant of fetal rat.
Proteins were stained with Amido Schwarz.
band in the alphal-g10bulin region. These protein bands absent in adult
serum and liver supernatant were more clearly demonstrated in densitometric
profiles (Fig. 2). Disc electrophoretic location of AFP in fetal serum and
liver supernatant was demonstrated by acrylamide gel immunoelectrophoresis
with a monospecific anti-AFP serum (Fig. 3). The single precipitin arcs of
AFP were formed behind the albumin band, corresponding to the bands of
protein absent in the adult serum and liver supernatant. These protein bands
which were seen on the conventional polyacrylamide gel are thus at least
partly AFP.
AFP contents in fetal serum and lirer: The AFP concentration in the
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Fig. 2. Densitometric profiles of serum and liver supernatant proteins from adult and
fetal rats on polyacrylamide gel electrophoresis. The stained gels shown in Fig. I were
scanned from left (bottom) to right (top) by a densitometer. Electrophoretic locations of
BPB and albumin are shown at the bottom of the figure. The numbers on the densitome-
tric profiles correspond to those of gels shown in Fig. 1.
serum of fetal rats used in the experiment was estimated to be 6.8 mg/ml and
9.2 mg/ml by disc electrophoresis and radioimmunoassay techniques, respec-
tively. On the other hand, the liver AFP level of the same fetal rats was
determined to be approximately 2.1 mg and 1.2 mgjg wet liver weight, re-
spectively, by the same two techniques.
Purification of AFP: Rat AFP was purified from pooled fetal serum and
liver by using an immunoadsorbent column of Sepharose 4B coupled with
4
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rabbit antibody to rat serum AFP by means of cyanogen bromide. For this
purpose, an antibody-rich gamma-globulin fraction was isolated from specific
anti-AFP serum by conventional ammonium sulfate fractionation (see Fig. 4,
Column 1) and lyophilized. The lyophilized gamma-globulin fraction (1.3 g
protein) was dissolved in 30 ml of 0.1 M NaHC03, added to Sepharose 4B
(7.5 g) activated previously with cyanogen bromide and mixed mechanically
for 6 hr at 4°0. The Sepharose-antibody conjugate was then washed
extensively with saline and packed in a column (2 X 50 cm). Nearly com-
plete adsorption of gamma-globulin on Sepharose 4B in this step was confirmed
by analysis of unadsorbed proteins (Fig. 4, Column 2). The AFP fraction
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obtained from fetal serum (Fig. 4, Column 3) or liver supernatant by 43%
saturation of ammonium sulfate was applied to the column coupled with the
antibody-rich globulin. The column was washed exhaustively with saline
until no protein was eluted. The protein washed out in this step was mostly
albumin, and AFP was specifically bound to anti-AFP-Sepharose 4B (Fig. 4,
Column 4). AFP was then eluted with 0.1 M glycine-Hel buffer, pH 2.8, at
a flow rate of 15J ml/hr and immediately neutralized with 0.5 M phosphate
buffer, pH 7.3. The AFP fraction was concentrated by ultrafiltration and
further purified by gel filtration on a Sephadex G-~OO column, which was
equilibrated with saline, to remove small amounts of contaminating proteins
1
2
3
4
I
Origin
Fig. 3. Disc electrophoretic location of AFP in fetal serum and liver super-
natant on polyacrylamide gels. Three ,d of fetal serum (Plates 1 and 2) and 10,ul
fetal liver supernatant (Plates 3 and 4) were applied on 7% polyacrylamide gels and
electrophoresed, as described in the legend to Fig. 1. Electrophoresed gels were
stained for protein with Amido Schwarz (Plates 2 and 4). Identical gels were placed
on glass plates and covered with 1.5% Difco-Noble agar at 50°C (Plates 1 and 3).
Double-diffusion test was performed after the specific anti-AFP serum was put
into troughs of Plates 1 and 3. A faint precipitin line for liver supernatant is
indicated by the arrow (Plate 3).
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Fig. 5. Immunological identity of AFP
purified from fetal serum and liver. Each
100,ug of AFP purified from fetal serum and
liver was electrophoresed on 7% polyacry-
lamide gel. Portions of electrophoresed gels
behind BPB-bound albumin and correspond-
ing to the position of AFP migration were
cut in 5 mm thickness and placed into the
outer larger wells (Wells 1 and 2). Portions
of the gel at origin were cut out similarly
and put into the remaining outer well (Well
3) as a control. The center well contained
specific anti-AFP serum.
54321
+..............._ ..........
eluted in the void volume of the
column.
Disc electrophoresis of the puri-
fied AFP from fetal serum on 7%
polyacrylamide gels revealed two
components with R BPB of 0.58 and
0.55; the relative amounts of each
component being 35% and 65%, re-
spectively (Fig. 4, Column 5). Identical results were obtained with similarly
purified liver AFP, although the crude liver supernatant revealed only one
protein band lacking in adult liver supernatant. The protein band corres-
ponding to R BPB of 0.58 found in fetal serum would also be present in the fetal
liver supernatant but was not distinctly observed on stained gels because of
the much lower AFP content as compared with other liver proteins. The fast
and slow migrating components are referred to as AFPa and AFPb, as pre-
viously reported (1, 3). AFPa and AFPb which were electrophoretically
separated from the purified AFP reacted identically with the antiserum in the
Ouchterlony test, indicating no immunological difference between the two
components.
Electrophoretic and immunochemical properties of purified AFP f10m fetal
Fig. 4. Disc electrophoretic patterns of
protein preparations from anti-AFP serum
and fetal serum obtained during purification
of rat AFP. Each 5O-120,ug of protein sam-
ple was put on 7% polyacrylamide gel
column and electrophoresed. Samples ap-
plied were as follows: 1, antibody-rich
gamma-globulin fraction isolated from mono-
specific anti-AFP serum by conventional
ammonium sulfate fractionation; 2, unad-
sorbed proteins on Sepharose 4B from anti-
body-rich gamma-globulin fraction; 3, AFP-
rich fraction of fetal serum isolated by 43%
saturation of ammonium sulfate; 4, unad-
sorbed fraction from AFP-rich fraction of
fetal serum on anti-AFP antibody-bound
Sepharose 4B; and 5, a purified AFP prepa-
ration eluted with 0.1 M glycine buffer,
pH 2.8, from a column containing antigen
and antibody-bound Sepharose 4B.
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serum and liver: The purified preparations of AFP from fetal serum and liver
gave single "fused precipitin lines against the antiserum in Ouchterlony double-
diffusion analysis (Fig. 5).
Disc electrophoresis of the purified serum AFP treated with neuramini-
dase for 6 hr showed a clear separation into two bands with slower mobilities;
each of these bands appeared to be further composed of subcomponents. We
have previously demonstrated further heterogeneity of the neuraminidase-
treated serum AFP by using disc electrophoresis with 5% acrylamide monomer
(3). Therefore, the microheterogeneity of liver AFP treated with neurami-
nidase was also investigated by employing this analytical procedure. Electro-
phoresis .of the purified liver AFP treated for 12 hr with neuraminidase also
showed a clear separation into two bands with slower mobilities; R BPB
values of untreated AFPa" and AFPb were 0.88 and 0.85, respectively, and
those of treated components were 0.83 and 0.76, respectively (Fig. 6, Columns
3 and 4). The results were virtually identical to those with purified serum
+
1 2 3 4
0.7
0.8·
0.9
Fig. 6. Effect of neuraminidase treatment' on disc electrophoretic mobilities of
the two components of AFP purified from fetal serum and liver. Forty .~tg of AFP
were electrophoresed on 5% polyacrylamide gels for 70 min. Neuraminidase treat-
ment was carried out at 37°C for 12 hr as described under Materials and Methods.
1, untreated AFP purified from serum; 2, neuraminidase-treated AFP from serum;
3, untreated AFP purified from liver; and 4, neuraminidase-treated AFP from
liver. Neuraminidase ran off the gels after electrophoresis under the tested condi-
tion.
AFP (Fig. 6, Columns I and 2). The time dependent conversion of faster
into slower migrating components of AFPa (R BPs, 0.88 --'» 0.83) and AFPb
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(RBPB, 0.85 ~ 0.76) was previously observed with neuraminidase upon in-
cubation for varying periods of time, and no interconversion of these two
components was confirmed (3).
Immunoelectrophoresis of liver AFP treated for 6 hr with neuraminidase
revealed single precipitin lines with much slower mobilities, as obtained with
purified serum AFP (Fig. 7). This is a further confirmation of the fact that
purified AFP from both serum and liver similarly reacted with anti-AFP
Fig. 7. Immunoelectrophoresis of neuraminidase-treated AFP purified from
fetal serum and liver. Purified AFP was treated for 6 hr with neuraminidase.
1, untreated AFP purified from serum; 2, neuraminidase-treated AFP purified from
liver; and 3, neuraminidase-treated AFP from serum. Electrophoresis was carried
out at room temperature for 100 min on 1.5% agarose buffered at pH 8.6 with
12.5 mM barbital buffer. The electrophoresed plate received anti-AFP serum in
the troughs.
serum even when AFP was treated with neuraminidase (see Fig. 5). A distinct
immunoelectrophoretic separation of the two components in the purified
serum AFP treated with neuraminidase for 12 hr was successful on the agarose
plate (3).
Four bands of purified serum and liver AFP (R BP H; 0.85, 0.83, 0.78 and
0.76) obtained by treatment with neuraminidase for 6 hr upon electrophoresis
were compared (Fig. 8). The relative amounts of protein in AFPa and AFPb
were found to be 33% and 67%, respectively, for serum AFP and 36% and
64%, respectively, for liver AFP.
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Fig. 8. Disc electrophoretic patterns of neuraminidase-treated AFP purified
from fetal serum and liver. AFP was treated for 6 hr with neuraminidase. Five
percent polyacrylamide gels were used for electophoresis of treated AFP.
DISCUSSION
Carbohydrate analysis of rat AFP purified from fetal serum has revealed
that AFP is a plasma glycoprotein (13). If attachment of carbohydrate moie-
ties to AFP occurs by various glycosyltransferases after the release of newly
synthesized AFP from the ribosome, the carbohydrate units of AFP present
in liver may differ from those of circulating AFP in blood. This is an inter-
esting problem to study since the different numbers of terminal sialic acid
residues of AFP in liver and circulating AFP may give different half lives,
functions and regulatory mechanisms in AFP synthesis. Thus, we have ini-
tiated a study on the microheterogeneity of AFP in liver, where it is mostly
synthesized, in an attempt to determine whether there are differences between
the liver and circulating plasma AFP. The results described above show that
the fetal serum and liver AFP are immunochemically and electrophoretically
indistinguishable from each other, even when the AFP was treated with
neuraminidase for various periods of time.
Many glycoproteins exhibit microheterogeneity due to variations in the
type and amount of carbohydrates attached to the polypeptide chains (14, 15).
In some samples of glycoprotein microheterogeneity have been related to the
variation in the amount of bound sialic acid (16, 17). Treatment of fetuin
(17) and human AFP (16, 18) with neuraminidase reduced the number of the
10
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electrophoretic bands, indicating that sialic acid is primarily responsible in
these cases for the observed microheterogeneity. However, the complete re-
moval of sialic acid from rat AFP revealed rather a more distinct separation
of the two components of fetoprotein, suggesting that structural features
other than those involving sialic residues must play an important role in
determining these two components. The differences in the number or ar-
rangement of amide groups, disulfide cross linkages or carbohydrate portions
other than sialic acid have been suggested as being responsible for the ob-
served microheterogeneity (3).
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